Published in Allergy Asthma Clin Immunol on December 15, 2007
Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol (1986) 35.41
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol (2005) 30.22
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol (2005) 27.17
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet (2001) 6.82
Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol (2005) 5.82
TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med (2005) 5.77
ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature (1999) 5.76
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med (2004) 3.83
Prevention of asthma during the first 5 years of life: a randomized controlled trial. J Allergy Clin Immunol (2006) 3.17
Toll-like receptor function and signaling. J Allergy Clin Immunol (2006) 3.17
Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol (2001) 3.02
T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription. J Exp Med (2006) 2.70
Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. J Immunol (2005) 2.51
Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat Immunol (2004) 2.43
Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med (1998) 2.01
Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J Allergy Clin Immunol (2004) 1.96
A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child (2006) 1.94
The many faces of the hygiene hypothesis. J Allergy Clin Immunol (2006) 1.94
The regulation of allergy and asthma. Immunol Rev (2006) 1.86
IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol (2006) 1.82
Intestinal helminths protect in a murine model of asthma. J Immunol (2006) 1.64
Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. Immunol Rev (2006) 1.56
Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J Exp Med (2001) 1.52
Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guérin in adult asthma. Clin Exp Allergy (2004) 1.51
Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model. J Immunol (2004) 1.46
The roles for cytokines in the generation and maintenance of regulatory T cells. Immunol Rev (2006) 1.46
Childhood asthma: new insights into management. J Allergy Clin Immunol (2002) 1.42
Origins of the T(H)1-T(H)2 model: a personal perspective. Nat Immunol (2006) 1.38
BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol (1998) 1.35
Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin Immunol (2001) 1.19
Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults. J Med Genet (2004) 1.19
RNA interference: the molecular immune system. J Mol Histol (2004) 1.16
FOXP3 ensembles in T-cell regulation. Immunol Rev (2006) 1.15
Signaling pathways regulating interleukin-13-stimulated chemokine release from airway smooth muscle. Am J Respir Crit Care Med (2003) 1.15
Activation of invariant NKT cells by the helminth parasite schistosoma mansoni. J Immunol (2006) 1.13
Lyn, Jak2, and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation. J Exp Med (1998) 1.12
The role of Toll-like receptors and related receptors of the innate immune system in asthma. Curr Opin Allergy Clin Immunol (2006) 1.08
Proteases in helminth- and allergen- induced inflammatory responses. Chem Immunol Allergy (2006) 1.06
Helminth infection with Litomosoides sigmodontis induces regulatory T cells and inhibits allergic sensitization, airway inflammation, and hyperreactivity in a murine asthma model. J Immunol (2008) 1.06
The allergy epidemic extends beyond the past few decades. Clin Exp Allergy (2004) 1.06
Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration. J Immunol (1999) 1.05
Targeted disruption of stat6 DNA binding activity by an oligonucleotide decoy blocks IL-4-driven T(H)2 cell response. Blood (2000) 1.03
Suppression of allergic airway disease using mycobacterial lipoglycans. J Allergy Clin Immunol (2004) 1.01
Defining childhood atopic phenotypes to investigate the association of atopic sensitization with allergic disease. Allergy (2005) 1.01
Endotoxins prevent murine IgE production, T(H)2 immune responses, and development of airway eosinophilia but not airway hyperreactivity. J Allergy Clin Immunol (2002) 0.99
Exposure to endotoxin and allergen in early life and its effect on allergen sensitization in mice. J Allergy Clin Immunol (2003) 0.99
Regulation of mouse inducible costimulator (ICOS) expression by Fyn-NFATc2 and ERK signaling in T cells. J Biol Chem (2006) 0.99
STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation. Int Immunol (2004) 0.99
Toll-like receptor ligands and atopy: a coin with at least two sides. J Allergy Clin Immunol (2006) 0.97
Cytokines or their antagonists for the treatment of asthma. Chest (2006) 0.96
The role of helminth infections in protection from atopic disorders. Curr Opin Allergy Clin Immunol (2005) 0.95
Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice. Clin Exp Allergy (2004) 0.95
Immunologic responses to common antigens in helminthic infections and allergic disease. Curr Opin Allergy Clin Immunol (2005) 0.94
Sensitization to airborne environmental allergens: unresolved issues. Nat Immunol (2005) 0.94
Neonatal exposure with LPS and/or allergen prevents experimental allergic airways disease: development of tolerance using environmental antigens. J Allergy Clin Immunol (2006) 0.94
Treatment of allergic airway inflammation and hyperresponsiveness by imiquimod modulating transcription factors T-bet and GATA-3. Chin Med J (Engl) (2006) 0.92
Intragastric administration of Mycobacterium vaccae inhibits severe pulmonary allergic inflammation in a mouse model. Clin Exp Allergy (2005) 0.91
Perspectives in asthma: molecular use of microbial products in asthma prevention and treatment. J Allergy Clin Immunol (2005) 0.91
RNA interference decreases PAR-2 expression and function in human airway smooth muscle cells. Am J Respir Cell Mol Biol (2005) 0.91
Filarial nematode secreted product ES-62 is an anti-inflammatory agent: therapeutic potential of small molecule derivatives and ES-62 peptide mimetics. Clin Exp Pharmacol Physiol (2006) 0.89
Prenatal initiation of endotoxin airway exposure prevents subsequent allergen-induced sensitization and airway inflammation in mice. J Allergy Clin Immunol (2006) 0.89
Bacillus Calmette-Guerin, Mycobacterium bovis, as an immunomodulator in atopic diseases. Immunol Allergy Clin North Am (2006) 0.88
Inhibitors of mitogen-activated protein kinases differentially regulate costimulated T cell cytokine production and mouse airway eosinophilia. Respir Res (2005) 0.86
Inhibition of signal transducer and activator of transcription 1 attenuates allergen-induced airway inflammation and hyperreactivity. J Allergy Clin Immunol (2004) 0.86
Preventive and curative effects of probiotics in atopic patients. Med Hypotheses (2005) 0.84
Antisense- and RNA interference-based therapeutic strategies in allergy. J Cell Mol Med (2005) 0.82
Inhalation of stable dust extract prevents allergen induced airway inflammation and hyperresponsiveness. Thorax (2005) 0.82
The in vitro and in vivo pharmacology of antisense oligonucleotides targeted to murine Stat6. Inflamm Res (2000) 0.77
Early identification of atopy in the prediction of persistent asthma in children. Lancet (2008) 2.27
Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J Exp Med (2003) 1.89
A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids. Respir Res (2015) 1.50
A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J Immunol (2008) 1.43
Inflammatory markers in induced sputum of school children born before 32 completed weeks of gestation. J Pediatr (2012) 1.41
Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhood. J Allergy Clin Immunol (2013) 1.36
Prenatal stress enhances susceptibility of murine adult offspring toward airway inflammation. J Immunol (2006) 1.24
Small interfering RNA against transcription factor STAT6 inhibits allergic airway inflammation and hyperreactivity in mice. J Immunol (2009) 1.15
Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs. J Allergy Clin Immunol (2012) 1.06
Helminth infection with Litomosoides sigmodontis induces regulatory T cells and inhibits allergic sensitization, airway inflammation, and hyperreactivity in a murine asthma model. J Immunol (2008) 1.06
Mothers in stress: consequences for the offspring. Am J Reprod Immunol (2005) 1.03
Animal models of airway sensitization. Curr Protoc Immunol (2007) 1.02
Endotoxins prevent murine IgE production, T(H)2 immune responses, and development of airway eosinophilia but not airway hyperreactivity. J Allergy Clin Immunol (2002) 0.99
Exposure to endotoxin and allergen in early life and its effect on allergen sensitization in mice. J Allergy Clin Immunol (2003) 0.99
Parental tobacco smoking is associated with augmented IL-13 secretion in children with allergic asthma. J Allergy Clin Immunol (2005) 0.99
Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy (2012) 0.97
T-cell costimulatory molecules: optimal targets for the treatment of allergic airway disease with monoclonal antibodies. J Allergy Clin Immunol (2005) 0.94
Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy. Pediatr Allergy Immunol (2013) 0.94
CD8(+) T cells regulate immune responses in a murine model of allergen-induced sensitization and airway inflammation. Eur J Immunol (2004) 0.92
Cis-9,trans-11-conjugated linoleic acid inhibits allergic sensitization and airway inflammation via a PPARgamma-related mechanism in mice. J Nutr (2008) 0.90
Mycobacteria and allergies. Immunobiology (2007) 0.89
Prenatal initiation of endotoxin airway exposure prevents subsequent allergen-induced sensitization and airway inflammation in mice. J Allergy Clin Immunol (2006) 0.89
Inducible costimulator-positive T cells are required for allergen-induced local B-cell infiltration and antigen-specific IgE production in lung tissue. J Allergy Clin Immunol (2004) 0.87
Trans-10,cis-12-CLA-caused lipodystrophy is associated with profound changes of fatty acid profiles of liver, white adipose tissue and erythrocytes in mice: possible link to tissue-specific alterations of fatty acid desaturation. Ann Nutr Metab (2010) 0.86
Inhibition of signal transducer and activator of transcription 1 attenuates allergen-induced airway inflammation and hyperreactivity. J Allergy Clin Immunol (2004) 0.86
A nematode immunomodulator suppresses grass pollen-specific allergic responses by controlling excessive Th2 inflammation. Int J Parasitol (2012) 0.85
Oral application of bacterial lysate in infancy decreases the risk of atopic dermatitis in children with 1 atopic parent in a randomized, placebo-controlled trial. J Allergy Clin Immunol (2012) 0.84
Pathway focused protein profiling indicates differential function for IL-1B, -18 and VEGF during initiation and resolution of lung inflammation evoked by carbon nanoparticle exposure in mice. Part Fibre Toxicol (2009) 0.83
Rho-kinase and contractile apparatus proteins in murine airway hyperresponsiveness. Exp Toxicol Pathol (2008) 0.82
Oral administration of bacterial lysates attenuates experimental food allergy. Int Arch Allergy Immunol (2011) 0.82
Safety evaluation of pulmonary influenza vaccination in healthy and "asthmatic" mice. Vaccine (2008) 0.82
Corticosteroid treatment in bronchial asthma: for better or for worse? J Allergy Clin Immunol (2003) 0.80
Detection of allergen-induced airway hyperresponsiveness in isolated mouse lungs. Am J Physiol Lung Cell Mol Physiol (2006) 0.80
Lipopolysaccharide stimulation of dendritic cells induces interleukin-10 producing allergen-specific T cells in vitro but fails to prevent allergic airway disease. Exp Lung Res (2009) 0.80
Looking into the future of Trichuris suis therapy. J Allergy Clin Immunol (2010) 0.79
The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis. J Allergy Clin Immunol (2002) 0.78
Anti-IgE therapy in allergic asthma. Curr Drug Targets Inflamm Allergy (2005) 0.78
Lipopolysaccharides modulate allergen-specific immune regulation in a murine model of mucosal tolerance induction. Int Arch Allergy Immunol (2008) 0.78
Effects of established allergen sensitization on immune and airway responses after secondary allergen sensitization. J Allergy Clin Immunol (2006) 0.78
Omalizumab (Xolair) in children with seasonal allergic rhinitis: leukotriene release as a potential in vitro parameter to monitor therapeutic effects. Pediatr Allergy Immunol (2007) 0.78
The role of anti-IgE therapy in combination with allergen specific immunotherapy for seasonal allergic rhinitis. BioDrugs (2007) 0.78
Impaired resolution of inflammatory response in the lungs of JF1/Msf mice following carbon nanoparticle instillation. Respir Res (2011) 0.77
Toll-like receptors--novel targets in allergic airway disease (probiotics, friends and relatives). Eur J Pharmacol (2006) 0.77
The role of baseline impedance as a marker of mucosal integrity in children with gastro esophageal reflux disease. Scand J Gastroenterol (2013) 0.77
ICOS-gene variants are not associated with atopic disease susceptibility in European children. Pediatr Allergy Immunol (2008) 0.77
Different isoforms of glutathione peroxidase cause opposing effects during the development of allergic asthma in mice. Antioxid Redox Signal (2010) 0.76
Nucleotide oligomerization domain 1 ligation suppressed murine allergen-specific T-cell proliferation and airway hyperresponsiveness. Am J Respir Cell Mol Biol (2014) 0.76
Targeting allergic airway diseases by siRNA: an option for the future? Curr Mol Med (2009) 0.76
Development of an animal model to evaluate the allergenicity of food allergens. Int Arch Allergy Immunol (2014) 0.76
Anti-IgE therapy combined with specific immunotherapy: pro. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M (2003) 0.75
Anti-IgE therapy. Clin Allergy Immunol (2004) 0.75
Hydrolyzed Formula With Reduced Protein Content Supports Adequate Growth: A Randomized Controlled Non-Inferiority Trial. J Pediatr Gastroenterol Nutr (2017) 0.75